BioCentury
ARTICLE | Finance

Helsinn looks upstream

Why Helsinn launched VC fund to invest in early stage companies

October 17, 2016 7:00 AM UTC

Helsinn Investment Fund S.A. is primarily looking for financial returns, but the new early stage venture fund's investment remit also could lead to deals that would expand Helsinn Healthcare S.A.'s specialty pharma pipeline into new therapeutic areas.

On Oct. 10, parent organization Helsinn Group launched the fund with $50 million to invest in early stage companies developing cancer therapeutics, diagnostics and supportive care products and companies working in metabolic, gastrointestinal and dermatology indications. ...